2-Chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-N-((3S,4S)-4-(3,4-difluorophenyl)piperidin-3-yl)-6-fluorobenzamide Hydrochloride

ID: ALA4877032

Chembl Id: CHEMBL4877032

PubChem CID: 164627719

Max Phase: Preclinical

Molecular Formula: C22H20Cl3F3N4O

Molecular Weight: 483.32

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  Cl.Cn1ncc(Cl)c1-c1cc(F)c(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(F)c(F)c2)c(Cl)c1

Standard InChI:  InChI=1S/C22H19Cl2F3N4O.ClH/c1-31-21(15(24)9-29-31)12-6-14(23)20(18(27)8-12)22(32)30-19-10-28-5-4-13(19)11-2-3-16(25)17(26)7-11;/h2-3,6-9,13,19,28H,4-5,10H2,1H3,(H,30,32);1H/t13-,19+;/m0./s1

Standard InChI Key:  XQQANTLXYIQICD-IBFMDKPJSA-N

Associated Targets(Human)

AKT1 Tchem Serine/threonine-protein kinase AKT (9192 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HGC-27 (1452 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
786-0 (47912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KHOS/NP (40 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 483.32Molecular Weight (Monoisotopic): 482.0888AlogP: 4.69#Rotatable Bonds: 4
Polar Surface Area: 58.95Molecular Species: BASEHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.03CX Basic pKa: 9.20CX LogP: 4.28CX LogD: 2.49
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.57Np Likeness Score: -1.14

References

1. Che J, Dai X, Gao J, Sheng H, Zhan W, Lu Y, Li D, Gao Z, Jin Z, Chen B, Luo P, Yang B, Hu Y, He Q, Weng Q, Dong X..  (2021)  Discovery of N-((3S,4S)-4-(3,4-Difluorophenyl)piperidin-3-yl)-2-fluoro-4-(1-methyl-1H-pyrazol-5-yl)benzamide (Hu7691), a Potent and Selective Akt Inhibitor That Enables Decrease of Cutaneous Toxicity.,  64  (16.0): [PMID:34375113] [10.1021/acs.jmedchem.1c00815]

Source